Skip to main content
Premium Trial:

Request an Annual Quote

Rafael Fonseca, Joseph M.K. Irudayaraj, Edward Maggio, Andrew Parkinson, Sangeeta Bhatia, Douglas Hixson

Premium

Rafael Fonseca has been named to the Mayo Clinic of Scottsdale, Ariz., and the Translational Genomics Institute of Phoenix to to lead a collaborative research project investigating biology, genetics, and targeted treatment of multiple myeloma, the institutes announced in May. Fonseca holds an MD from Universidad Anahuac of Mexico.


Joseph M.K. Irudayaraj, an associate professor of agricultural engineering at the Pennsylvania State University, has taken a leave of absence to conduct collaborative research on the interaction of biomolecules with inorganic surfaces for its integration with electronics for biosensor development, which has applications for food safety and homeland security, at the University of Wisconsin.


Edward Maggio, Andrew Parkinson, Sangeeta Bhatia, and Douglas Hixson join the advisory board of MultiCell Technologies of Warwick, RI.

Parkinson is the founder, chairman and chief executive officer of XenoTech. He holds a bachelor’s of science in medicinal biochemistry from the University of Surrey, England, and a PhD in biological chemistry from the University of Guelph in Ontario, Canada. He is also associate director of the Center for Environmental and Occupational Health and professor of pharmacology and toxicology at the University of Kansas Medical Center. Bhatia, an associate professor in the department of bioengineering and an associate adjunct professor in gastroenterology in the department of medicine at the University of California, San Diego, holds an MD from Harvard Medical School, and a PhD in biomedical engineering from the Massachusetts Institute of Technology. Maggio is CEO and founder of Cengent Therapeutics and the former president and CEO of ImmunoPharmaceutics. He holds a PhD from the University of Michigan. Hixson is vice president and co-founder of Prothera Biologics, a professor at Brown University, and the Director of the COBRE Center for Cancer Research at Rhode Island Hospital. He is also a research professor of medicine and pathology at Brown University. Hixon holds a BS in mathematics.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.